Meanwhile, during the transport of nanovesicles from blood to tumors, CP1-LVs could dynamically adsorb a large number of tumor-associated proteins, such as CD44 and osteopontin (OPN) with low isoelectric point which could bind to the amino groups of CP1-LVs, resulting in improved selective uptake in tumor cells. This evidence concerns the gene CD44 and neoplasm.